Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
osteoarthritis
Biotech
Ampio prepares to wind down after final therapeutic dream dies
With its sole remaining asset having failed to even enter the clinic, Ampio Pharmaceuticals has decided to call it a day.
James Waldron
Mar 26, 2024 9:01am
Ampio’s last shot at success fizzles out in preclinical stage
Feb 15, 2024 7:10am
Seizure drug mechanism could treat osteoarthritis
Jan 5, 2024 10:22am
Why Lilly is 'swimming against tide' by persevering with pain
Jun 5, 2023 5:00am
Moximed struts to FDA approval for knee shock absorber implant
Apr 13, 2023 10:30am
New osteoarthritis drug curbs symptoms in animals
Mar 22, 2023 2:28pm